HBSAG LEVELS AT SIX MONTHS POST-TREATMENT PREDICT SUSTAINED RESPONSE THROUGH LONG-TERM FOLLOW-UP IN HBEAG-POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALFA-2B

被引：0
|
作者：
Sonneveld, Milan J. [1 ]
Rijckborst, Vincent [1 ]
Zoutendijk, Roeland [1 ]
Gerken, Guido [2 ]
Tabak, Fehmi [3 ]
Mach, Tomasz H. [4 ]
Boucher, Charles A. [1 ]
Hansen, Bettina E. [1 ]
Janssen, Harry L. [1 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC, Rotterdam, Netherlands
[2] Univ Essen Gesamthsch, Essen, Germany
[3] Istanbul Univ, Cerrahpasa Med Sch, Istanbul, Turkey
[4] Coll Med UJ, Krakow, Poland
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1030A / 1030A
页数：1
相关论文
共 50 条
  • [21] Week 24 HBsAg levels predict response to peginterferon alfa-2b in HBeAg-positive genotype B or C chronic hepatitis B patients not meeting a week 12 stopping-rule
    Sonneveld, Milan J.
    Cheng, Jun
    Xie, Qing
    Hansen, Bettina E.
    Hou, Jin-Lin
    Tabak, Fehmi
    Zeuzem, Stefan
    Janssen, Harry L.
    HEPATOLOGY, 2015, 62 : 1189A - 1190A
  • [22] Sustained virologic response after peginterferon alfa-2b and ribavirin treatment predicts long-term clearance of HCV at 5-year follow-up
    Manns, M.
    Lindsay, K. L.
    Gordon, S. C.
    Pockros, P. J.
    Haeussinger, D.
    Hadziyiannis, S.
    Schmidt, W.
    Jacobson, I.
    Barcena, R.
    Schiff, E.
    Shaikh, O. S.
    Bacon, B.
    Marcellin, P.
    Smith, C.
    McHutchison, J. G.
    Deng, W.
    Pedicone, L. D.
    Albrecht, J. K.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S300 - S300
  • [23] New treatment strategy: switching from long-term entecavir to peginterferon alfa-2a induces HBeAg seroconversion/HBsAg clearance in patients with HBeAg-positive chronic hepatitis B
    Ning, Qin
    Han, Meifang
    Sun, Yongtao
    Jiang, Jia-ji
    Tan, Deming
    Hou, Jinlin
    Tang, Hong
    Sheng, Jifang
    Zhao, Mianzhi
    HEPATOLOGY, 2012, 56 : 300A - 301A
  • [24] A GENOTYPE-SPECIFIC BASELINE SCORE TO PREDICT POST-TREATMENT RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-POSITIVE PATIENTS WITH HEPATITIS B VIRUS GENOTYPE B OR C INFECTION
    Chan, H. L. -Y.
    Messinger, D.
    Papatheodoridis, G. V.
    Cornberg, M.
    Xie, Q.
    Piratvisuth, T.
    Ren, H.
    Kennedy, P.
    Thompson, A. J.
    Caputo, A.
    Bakalos, G.
    Pavlovic, V.
    Lampertico, P.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S589 - S590
  • [25] CONSOLIDATION THERAPY WITH ENTECAVIR CAN PREVENT POST-TREATMENT HBsAg REBOUND IN HBeAg-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON ALPHA
    Brouwer, W. P.
    Sonneveld, M. J.
    Xie, Q.
    Zhang, N.
    Zeuzem, S.
    Tabak, F.
    Zhang, Q.
    Simon, K.
    Akarca, U. S.
    Streinu-Cercel, A.
    Hansen, B.
    Janssen, H. L.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S572 - S573
  • [26] High rates of HBsAg seroconversion in HBeAg-positive chronic hepatitis B patients responding to interferon: A long-term follow-up study
    Moucari, Rami
    Korevaar, Anneke
    Lada, Olivier
    Martinot-Peignoux, Michelle
    Boyer, Nathalie
    Mackiewicz, Vincent
    Dauvergne, Agnes
    Cardoso, Ana C.
    Asselah, Tarik
    Nicolas-Chanoine, Marie-Helene
    Vidaud, Michel
    Valla, Dominique
    Bedossa, Pierre
    Marcellin, Patrick
    JOURNAL OF HEPATOLOGY, 2009, 50 (06) : 1084 - 1092
  • [27] Ultra-Long-term Follow-up of Interferon Alfa Treatment for HBeAg-Positive Chronic Hepatitis B Virus Infection
    Choi, Hannah S. J.
    van Campenhout, Margo J. H.
    van Vuuren, Anneke J.
    Krassenburg, Lisette A. P.
    Sonneveld, Milan J.
    de Knegt, Robert J.
    Hansen, Bettina E.
    Janssen, Harry L. A.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2021, 19 (09) : 1933 - +
  • [28] Long-term follow-up of peginterferon α treatment of HBeAg-positive chronic hepatitis B patients in phase III study of peginterferon α-2b (40kD, Y Shape) (Pegberon)
    Hou, Fengqin
    Shang, Jia
    Zhang, Mingxiang
    Pan, Chen
    Peng, Yan-zhong
    Chen, Shijun
    Zhang, Dazhi
    Zhao, Wei
    Mao, Qian-guo
    Mao, Qing
    Chen, Yongping
    Wang, Maorong
    Yin, Chibiao
    Peng, Jie
    Wang, Hao
    Meng, Qinghua
    Tan, Deming
    Sun, Li
    Wang, Guiqiang
    HEPATOLOGY, 2017, 66 : 502A - 503A
  • [29] A practical tool to predict response to peginterferon alfa-2a in Asian patients with HBeAg-positive chronic hepatitis B
    Chow, Wan Cheng
    Cooksley, Graham
    Piratvisuth, Teerha
    Lau, George Kk
    Mccloud, Philip
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A32 - A32
  • [30] IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B HBSAG SERUM LEVELS EARLY DURING TREATMENT WITH PEGINTERFERON ALFA-2A PREDICT HBSAG CLEARANCE 4 YEARS POST-TREATMENT
    Marcellin, Patrick
    Brunetto, Maurizia
    Bonino, Ferruccio
    Hadziyannis, Stephanos J.
    Kapprell, Hans-Peter
    McCloud, Philip I.
    Batrla, Richard
    HEPATOLOGY, 2008, 48 (04) : 718A - 719A
12345